Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001350489 | SCV001544889 | uncertain significance | Bloom syndrome | 2021-09-10 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with BLM-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 478 of the BLM protein (p.Gly478Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine. |
Natera, |
RCV001350489 | SCV002090037 | uncertain significance | Bloom syndrome | 2021-08-24 | no assertion criteria provided | clinical testing |